Batsheva Kerem

12.2k citations

98 papers · 8.0k indexed · 3 hit papers · h-index 48

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Tracheal and airway disorders
Genetics top 1%
- Genetics and Neurodevelopmental Disorders
- Congenital Ear and Nasal Anomalies

Papers in

Genetics 19
- Genetics and Neurodevelopmental Disorders 24
- Congenital Ear and Nasal Anomalies 11
- Genomic variations and chromosomal abnormalities 8
Pulmonary and Respiratory Medicine 43
- Cystic Fibrosis Research Advances 42
- Neonatal Respiratory Health Research 16
- Tracheal and airway disorders 9

Co-authors: Eitan Kerem Johanna M. Rommens Malka Nissim‐Rafinia Lap‐Chee Tsui Assaf C. Bester D. Markiewicz Liat Linde Peter R. Durie
Journals: Journal of Cystic Fibrosis (7 papers)Trends in Genetics (4 papers)Pediatric Pulmonology (4 papers)Nature Communications (3 papers)New England Journal of Medicine (3 papers)
Partner nations: Israel United States Canada

In The Last Decade

Batsheva Kerem

97 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development 2011 · 635 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Cell
1991 Genomics
1990 New England Journal of Medicine

Peers

Countries citing papers authored by Batsheva Kerem

Since Specialization

Citations

This map shows the geographic impact of Batsheva Kerem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Batsheva Kerem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Batsheva Kerem more than expected).

Fields of papers citing papers by Batsheva Kerem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Batsheva Kerem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Batsheva Kerem. The network helps show where Batsheva Kerem may publish in the future.

Co-authors

The 25 scholars most cited alongside Batsheva Kerem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Batsheva Kerem Line = papers co-authored together Batsheva Kerem links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis Journal of Cystic Fibrosis ·Norm Allaire, Uta Griesenbach, Batsheva Kerem, John D. Lueck, Noemie Stanleigh, Yifat S. Oren	2023	15
2	Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation Journal of Cystic Fibrosis ·Yifat S. Oren, O. Avizur-Barchad, E. Ozeri-Galai, R. Elgrabli, Meital R. Schirelman, Tehilla Blinder, Chava D. Stampfer, Merav Ordan, Onofrio Laselva, Malena Cohen‐Cymberknoh, Eitan Kerem, Christine E. Bear, Batsheva Kerem	2021	22
3	New approaches to genetic therapies for cystic fibrosis Journal of Cystic Fibrosis ·A. Christopher Boyd, Shuling Guo, Lulu Huang, Batsheva Kerem, Yifat S. Oren, Amy Walker, Stephen L. Hart	2020	48
4	3D genome organization contributes to genome instability at fragile sites Nature Communications ·Dan Sarni, Takayo Sasaki, Michal Irony Tur-Sinai, Karin Miron, Juan Carlos Rivera‐Mulia, Brian Magnuson, Mats Ljungman, David M. Gilbert, Batsheva Kerem	2020	50
5	RESTORATION OF CFTR FUNCTION BY ANTISENSE OLIGONUCLEOTIDE SPLICING MODULATION Pediatric Pulmonology ·Yifat S. Oren, I. M. Tur-Sinai, E. Ozeri-Galai, O. Avizur, Venkateshwar Mutyam, Steve D. Wilton, Steven M. Rowe, Batsheva Kerem	2017	0
6	DNA replication stress drives fragile site instability Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Michal Irony‐Tur Sinai, Batsheva Kerem	2017	17
7	The presence of extra chromosomes leads to genomic instability Nature Communications ·Verena Passerini, E. Ozeri-Galai, Mirjam S. de Pagter, Neysan Donnelly, Sarah Schmalbrock, Wigard P. Kloosterman, Batsheva Kerem, Zuzana Štorchová	2016	205
8	Transcriptional Dynamics in Colorectal Carcinogenesis: New Insights into the Role of c-Myc and miR17 in Benign to Cancer Transformation Cancer Research ·Eyal Ben‐David, Assaf C. Bester, Sagiv Shifman, Batsheva Kerem	2014	18
9	The complex basis underlying common fragile site instability in cancer Trends in Genetics ·E. Ozeri-Galai, Assaf C. Bester, Batsheva Kerem	2012	68
10	Interplay between ATM and ATR in the regulation of common fragile site stability Oncogene ·E. Ozeri-Galai, Michal Schwartz, A Rahat, Batsheva Kerem	2007	50
11	Clinical, Genetic, and Electrophysiologic Characteristics of a New Pas‐Domain HERG Mutation (M124R) Causing Long QT Syndrome Annals of Noninvasive Electrocardiology ·Liat Shushi, Batsheva Kerem, Maya Goldmit, Asher Peretz, Bernard Attali, Aharon Medina, Jeffrey A. Towbin, Junko Kurokawa, Robert S. Kass, Jesaia Benhorin	2005	13
12	The molecular basis of common and rare fragile sites Cancer Letters ·Michal Schwartz, Eitan Zlotorynski, Batsheva Kerem	2005	118
13	Familial concordance of phenotype and microbial variation among siblings with CF Pediatric Pulmonology ·Elie Picard, Micha Aviram, Y. Yahav, Joseph Rivlin, Hanna Blau, Lea Bentur, Avraham Avital, Yael Villa, Shepard Schwartz, Batsheva Kerem, Eitan Kerem	2004	14
14	Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis andCFTRStop Mutations New England Journal of Medicine ·Michael Wilschanski, Yaacov Yahav, Yasmin Yaacov, Hannah Blau, Lea Bentur, Joseph Rivlin, Micha Aviram, Tali Bdolah‐Abram, Zsuzsa Bebők, Liat Shushi, Batsheva Kerem, Eitan Kerem	2003	376
15	Protein electrophoretic markers in Israel: compilation of data and genetic affinities Annals of Human Biology ·Avshalom Zoossmann‐Diskin, A. Joel, M Liron, Batsheva Kerem, Mordechai Shohat, Leah Peleg	2002	4
16	A Pilot Study of the Effect of Gentamicin on Nasal Potential Difference Measurements in Cystic Fibrosis Patients Carrying Stop Mutations American Journal of Respiratory and Critical Care Medicine ·Michael Wilschanski, CHAGIT FAMINI, Hannah Blau, Joseph Rivlin, A Augarten, Avraham Avital, Batsheva Kerem, Eitan Kerem	2000	151
17	Variable Levels of Normal RNA in Different Fetal Organs Carrying a Cystic Fibrosis Transmembrane Conductance Regulator Splicing Mutation American Journal of Respiratory and Critical Care Medicine ·Ornit Chiba‐Falek, Richard B. Parad, Eitan Kerem, Batsheva Kerem	1999	33
18	Cystic Fibrosis in Jews: Frequency and Mutation Distribution Genetic Testing ·Batsheva Kerem, Ornit Chiba‐Falek, Eitan Kerem	1997	57
19	A Cystic Fibrosis Transmembrane Conductance Regulator Splice Variant With Partial Penetrance Associated With Variable Cystic Fibrosis Presentations American Journal of Respiratory and Critical Care Medicine ·Eitan Kerem, Naama Rave-Harel, A Augarten, Igael Madgar, Malka Nissim‐Rafinia, Y. Yahav, Ran Goshen, Lea Bentur, Joseph Rivlin, Micha Aviram, Adnan Genem, Ornit Chiba‐Falek, Mhs Kraemer, A. Simón, David Branski, Batsheva Kerem	1997	63
20	The relationship between genotype and phenotype in cystic fibrosis Current Opinion in Pulmonary Medicine ·Eitan Kerem, Batsheva Kerem	1995	28

About Batsheva Kerem

Batsheva Kerem is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Speech and Hearing, having authored 98 papers that have together received 8.0k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (42 papers), Genetics and Neurodevelopmental Disorders (24 papers), DNA Repair Mechanisms (22 papers), Neonatal Respiratory Health Research (16 papers), Congenital Ear and Nasal Anomalies (11 papers), Tracheal and airway disorders (9 papers), Genomic variations and chromosomal abnormalities (8 papers) and Genomics and Chromatin Dynamics (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.2k citations), Genetics (746 citations), Genetics (1.8k citations), Molecular Biology (4.2k citations) and Cell Biology (565 citations). Batsheva Kerem has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Eitan Kerem, Johanna M. Rommens, Malka Nissim‐Rafinia, Lap‐Chee Tsui, Assaf C. Bester, D. Markiewicz, Liat Linde, Peter R. Durie, Yifat S. Oren and Julian Zielenski. Their work appears in journals such as Journal of Cystic Fibrosis, Trends in Genetics, Pediatric Pulmonology, Nature Communications and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact